Transient hematopoietic stem cell rescue using umbilical cord blood for a lethally irradiated nuclear accident victim

Bone Marrow Transplant. 2002 Feb;29(3):197-204. doi: 10.1038/sj.bmt.1703356.

Abstract

We performed stem cell rescue and allogeneic skin transplantation on a lethally neutron-irradiated nuclear accident victim. HLA-DRB1 mismatched unrelated umbilical cord blood cells (2.08 x 10(7)/kg recipient body weight) were transplanted to an 8-10 Gy equivalent neutron-irradiated patient because of a lack of a suitable bone marrow or peripheral blood donor. Pre-transplant conditioning consisted of anti-thymocyte gamma-globulin alone, and GVHD prophylaxis was a combination of cyclosporine (CYA) and methylprednisolone (mPSL). Granulocyte colony-stimulating factor (G-CSF), erythropoietin (EPO), and thrombopoietin (TPO) were concurrently administered after transplantation. The absolute neutrophil count reached 0.5 x 10(9)/l on day 15, the reticulocyte count rose above 1% on day 23, and the platelet count was over 50 x 10(9)/l on day 27, respectively. Cytogenetic studies of blood and marrow showed donor/recipient mixed chimerism. Rapid autologous hematopoietic recovery was recognized after withdrawal of CYA and mPSL. Repeated pathological examinations of the skin revealed no evidence of acute GVHD. Eighty-two days after the irradiation, skin transplantation was performed to treat radiation burns. Almost 90% of the transplanted skin engrafted. Immunological examination after autologous hematopoietic recovery revealed an almost normal T cell count. However, immune functions were severely impaired. The patient died from infectious complication 210 days after the accident.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Fatal Outcome
  • Fetal Blood / cytology
  • Graft Survival
  • Hematopoietic Stem Cell Transplantation*
  • Histocompatibility Testing
  • Humans
  • Immune System / growth & development
  • Male
  • Neutrons
  • Radiation Dosage
  • Radiation Injuries / pathology
  • Radiation Injuries / therapy*
  • Radioactive Hazard Release*
  • Respiratory Distress Syndrome / etiology
  • Skin Transplantation
  • Transplantation Chimera
  • Transplantation, Homologous